These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34615581)

  • 1. Effectiveness of GenoType MTBDR
    Ejo M; Van Deun A; Nunn A; Meredith S; Ahmed S; Dalai D; Tumenbayar O; Tsogt B; Dat PT; Ha DTM; Hang PT; Kokebu D; Teferi M; Mebrahtu T; Ngubane N; Moodliar R; Duckworth L; Conradie F; Enduwamahoro E; Keysers J; De Rijk P; Mulders W; Diro E; Rigouts L; de Jong BC; Torrea G
    Int J Tuberc Lung Dis; 2021 Oct; 25(10):839-845. PubMed ID: 34615581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
    Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance.
    Lee YS; Lee BY; Jo KW; Shim TS
    J Infect Chemother; 2017 Dec; 23(12):820-825. PubMed ID: 29066216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume Laboratory.
    Pillay S; de Vos M; Derendinger B; Streicher EM; Dolby T; Scott LA; Steinhobel AD; Warren RM; Theron G
    Clin Infect Dis; 2023 Feb; 76(3):e920-e929. PubMed ID: 35788278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    Rahman SMM; Nasrin R; Rahman A; Ahmed S; Khatun R; Uddin MKM; Rahman MM; Banu S
    PLoS One; 2021; 16(12):e0261329. PubMed ID: 34914803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of MTBDR
    Chandak RJ; Malhotra B; Bhargava S; Goel SK; Verma D; Tiwari J
    Int J Tuberc Lung Dis; 2019 Dec; 23(12):1257-1262. PubMed ID: 31931908
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
    Brossier F; Guindo D; Pham A; Reibel F; Sougakoff W; Veziris N; Aubry A
    J Clin Microbiol; 2016 Jun; 54(6):1573-1580. PubMed ID: 27053671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-line Drug Resistance Characterization in
    Sethi S; Agarwal P; Khaneja R; Kumar N; Kumar N; Chandna J; Aggarwal AN; Yadav R
    J Epidemiol Glob Health; 2020 Mar; 10(1):42-45. PubMed ID: 32175709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype MTBDRsl version 2 and phenotypic drug resistance detection of
    Radhakrishnan R; Prabuseenivasan S; Hannah S; Vaishanavee V; Senthildevi V; Kannadhasan T; Suchithra R; Rajendran P; Chinnaiyan P; Jayabal L; Frederick A; Shanmugam S
    Int J Mycobacteriol; 2023; 12(3):299-304. PubMed ID: 37721236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
    Sidiq Z; Hanif M; Dwivedi KK; Chopra KK; Khanna A; Vashishat BK
    Indian J Tuberc; 2023 Jul; 70(3):361-365. PubMed ID: 37562913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the MTBDRsl assay in Georgia.
    Tukvadze N; Bablishvili N; Apsindzelashvili R; Blumberg HM; Kempker RR
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):233-9. PubMed ID: 24429319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in Tunisia.
    Bouzouita I; Draoui H; Cabibbe AM; Essalah L; Bejaoui S; Trovato A; Messadi F; Cirillo DM; Slim-Saidi L
    Res Microbiol; 2021; 172(3):103816. PubMed ID: 33737037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
    J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the GenoType MTBDR
    Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
    J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
    Tagliani E; Cabibbe AM; Miotto P; Borroni E; Toro JC; Mansjö M; Hoffner S; Hillemann D; Zalutskaya A; Skrahina A; Cirillo DM
    J Clin Microbiol; 2015 Sep; 53(9):2961-9. PubMed ID: 26179309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.
    Surcouf C; Heng S; Pierre-Audigier C; Cadet-Daniel V; Namouchi A; Murray A; Gicquel B; Guillard B
    BMC Infect Dis; 2011 Sep; 11():255. PubMed ID: 21955640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.
    Desikan P; Panwalkar N; Chaudhuri S; Khan Z; Punde RP; Pauranik A; Mirza SB; Ranjan R; Anand S; Sachdeva KS
    Trans R Soc Trop Med Hyg; 2020 Apr; 114(4):249-254. PubMed ID: 32003797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.